NDAOPHTHALMICSOLUTION/DROPS
Approved
Aug 2025
Lifecycle
Launch
Competitive Pressure
0/100
Data completeness
3/8 — Basic
CYKLX (articaine hydrochloride) by Genomics is anesthetic. First approved in 2025.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CYKLX (articaine hydrochloride) is a local anesthetic administered as an ophthalmic solution for topical eye procedures. It works by blocking nerve impulse generation and conduction, with epinephrine added to prolong tissue concentration and reduce systemic absorption. The drug is indicated for local anesthesia in ophthalmic surgery and diagnostic procedures.
Launch12.9 years to LOE
Early-stage launch with minimal current commercial data; ophthalmic anesthetic market shows low competitive pressure, positioning this as a niche specialty product with focused team requirements.
Mechanism of Action
anesthetic. Local anesthetics block the generation and conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CYKLX positions you in a specialized ophthalmic anesthetic niche with minimal current job openings (1 linked role). Career growth depends on successful market penetration and potential indication expansion beyond ophthalmic surgery. Data and analytics roles dominate the early-stage team structure, reflecting post-launch pharmacovigilance and registry management priorities.
Data Manager
Worked on CYKLX at Genomics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.